The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...

For a century and a half, the sharp end of a needle has been the price of admission for modern medicine. Generations of ...

Comprehensive residue-level mapping of amyloid-beta recognition reveals how sequence variants, post-translational ...

In a warming corner of Iceland, tiny soil microbes are quietly rewriting one of Earth’s most fundamental life-support systems ...

The parents of a Derbyshire toddler who is one of 15 people across the world with a rare genetic condition have made a plea ...

Mir195 enables Ebf1-deficient hematopoietic progenitor cells to mature into B cells, suggesting some miRNA can substitute for transcription factors in differentiation.

Genomics company Illumina (NASDAQ:ILMN) in Q4 CY2025, with sales up 5% year on year to $1.16 billion. The company’s full-year ...

Scientists at the University of Virginia School of Medicine are chasing a new way to slow glioblastoma, the deadliest brain ...

According to Mordor Intelligence, the proteomics market size was valued at USD 29.92 billion in 2025 and projected to grow from USD 33.47 billion ...

According to Mordor Intelligence, the proteomics market size was valued at USD 29.92 billion in 2025 and projected to grow ...

Beyond analysts' top-and-bottom-line estimates for Illumina (ILMN), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ...

For instance, some products that are used to perform various in vitro diagnostic tests using various technologies involve real time PCR detection systems, immunoassay systems, and others. In vitro ...